Financials data is unavailable for this security.
View more
Year on year Ryman Healthcare Ltd had net income fall -98.15% from 257.84m to 4.78m despite a 20.83% increase in revenues from 570.98m to 689.89m.
| Gross margin | -- |
|---|---|
| Net profit margin | 0.69% |
| Operating margin | -39.69% |
| Return on assets | 0.04% |
|---|---|
| Return on equity | 0.11% |
| Return on investment | 0.07% |
More ▼
Cash flow in NZDView more
In 2024, Ryman Healthcare Ltd increased its cash reserves by 49.97%, or 13.93m. The company earned 658.48m from its operations for a Cash Flow Margin of 95.45%. In addition the company generated 197.50m cash from financing while 842.05m was spent on investing.
| Cash flow per share | 0.0706 |
|---|---|
| Price/Cash flow per share | 68.65 |
| Book value per share | 6.42 |
|---|---|
| Tangible book value per share | 6.30 |
More ▼
Balance sheet in NZDView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.5816 |
|---|---|
| Total debt/total capital | 0.3677 |
More ▼
Growth rates in NZD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -100.00% and -98.00%, respectively. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.85% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 0.00% |
| EPS growth(5 years) | -59.21 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -98.03 |
More ▼
